Ellen Mary Fay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ellen Mary Fay has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Joanna Francelle McGouran
RINN Pharma and Biopharma Centre School of Chemistry and Trinity Biomedical Sciences Institute Trinity College Dublin The University of Dublin Dublin Ireland
3 shared publications - Mark Berney
National Institute for Bioprocess Research and Training Foster Avenue Mount Merrion, Dublin Ireland
2 shared publications - Barbara Imperiali
Department of Biology Massachusetts Institute of Technology Cambridge Massachusetts USA
1 shared publication - Christine A. Arbour
Department of Biology and Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
1 shared publication - Eva-Maria Dürr
School of Chemistry and Trinity Biomedical Sciences Institute, Trinity College Dublin, the University of Dublin, Dublin 2 Ireland
1 shared publication John J. Deering
School of Chemistry and Trinity Biomedical Sciences Institute, Trinity College Dublin, the University of Dublin, Dublin 2 Ireland
1 shared publication
Latest Publications
- Open Access
- 5 September 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (21) , e202400528
Zinc‐Binding Oligonucleotide Backbone Modifications for Targeting a DNA‐Processing Metalloenzyme
A series of chemically‐modified oligonucleotides for targeting the DNA repair nuclease SNM1A have been designed and synthesised. Each oligonucleotide contains a modified internucleotide linkage designed to both mimic the native phosphodiester backbone and chelate to the catalytic zinc ion(s) in the SNM1A active site. Dinucleoside phosphoramidites containing urea, squaramide, sulfanylacetamide, and sulfinylacetamide linkages were prepared and employed successfully in solid‐phase oligonucleotide synthesis. All the modified oligonucleotides were found to interact with SNM1A in a gel electrophoresis‐based assay, demonstrating the first examples of inhibition of DNA damage repair enzymes for many of these groups in oligonucleotides. One strand containing a sulfinylacetamide‐linkage was found to have the strongest interaction with SNM1A and was further tested in a real‐time fluorescence assay. This allowed an IC50 value of 231 nM to be determined, significantly lower than previously reported substrate‐mimics targeting this enzyme. It is expected that these modified oligonucleotides will serve as a scaffold for the future development of fluorescent or biotin‐labelled probes for the in vivo study of DNA repair processes.
- 5 September 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (21) , e202400528
Open AccessZinc‐Binding Oligonucleotide Backbone Modifications for Targeting a DNA‐Processing Metalloenzyme
A series of chemically‐modified oligonucleotides for targeting the DNA repair nuclease SNM1A have been designed and synthesised. Each oligonucleotide contains a modified internucleotide linkage designed to both mimic the native phosphodiester backbone and chelate to the catalytic zinc ion(s) in the SNM1A active site. Dinucleoside phosphoramidites containing urea, squaramide, sulfanylacetamide, and sulfinylacetamide linkages were prepared and employed successfully in solid‐phase oligonucleotide synthesis. All the modified oligonucleotides were found to interact with SNM1A in a gel electrophoresis‐based assay, demonstrating the first examples of inhibition of DNA damage repair enzymes for many of these groups in oligonucleotides. One strand containing a sulfinylacetamide‐linkage was found to have the strongest interaction with SNM1A and was further tested in a real‐time fluorescence assay. This allowed an IC50 value of 231 nM to be determined, significantly lower than previously reported substrate‐mimics targeting this enzyme. It is expected that these modified oligonucleotides will serve as a scaffold for the future development of fluorescent or biotin‐labelled probes for the in vivo study of DNA repair processes.
- 26 June 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (28) , 5873-5879
Deploying solid-phase synthesis to access thymine-containing nucleoside analogs that inhibit DNA repair nuclease SNM1A
Nucleoside analogs show useful bioactive properties. A versatile solid-phase synthesis that readily enables the diversification of thymine-containing nucleoside analogs is presented. The utility of the approach is demonstrated with the preparation of a library of compounds for analysis with SNM1A, a DNA damage repair enzyme that contributes to cytotoxicity. This exploration provided the most promising nucleoside-derived inhibitor of SNM1A to date with an IC50 of 12.3 μM.
- 26 June 2023
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 21 (28) , 5873-5879
Deploying solid-phase synthesis to access thymine-containing nucleoside analogs that inhibit DNA repair nuclease SNM1A
Nucleoside analogs show useful bioactive properties. A versatile solid-phase synthesis that readily enables the diversification of thymine-containing nucleoside analogs is presented. The utility of the approach is demonstrated with the preparation of a library of compounds for analysis with SNM1A, a DNA damage repair enzyme that contributes to cytotoxicity. This exploration provided the most promising nucleoside-derived inhibitor of SNM1A to date with an IC50 of 12.3 μM.
- Open Access
- 14 December 2021
- Published by Wiley in ChemMedChem
- Vol. 17 (5) , e202100603
5’‐Phosphorylation Increases the Efficacy of Nucleoside Inhibitors of the DNA Repair Enzyme SNM1A
Certain cancers exhibit upregulation of DNA interstrand crosslink repair pathways, which contributes to resistance to crosslinking chemotherapy drugs and poor prognoses. Inhibition of enzymes implicated in interstrand crosslink repair is therefore a promising strategy for improving the efficacy of cancer treatment. One such target enzyme is SNM1A, a zinc co‐ordinating 5’–3’ exonuclease. Previous studies have demonstrated the feasibility of inhibiting SNM1A using modified nucleosides appended with zinc‐binding groups. In this work, we sought to develop more effective SNM1A inhibitors by exploiting interactions with the phosphate‐binding pocket adjacent to the enzyme's active site, in addition to the catalytic zinc ions. A series of nucleoside derivatives bearing phosphate moieties at the 5’‐position, as well as zinc‐binding groups at the 3’‐position, were prepared and tested in gel‐electrophoresis and real‐time fluorescence assays. As well as investigating novel zinc‐binding groups, we found that incorporation of a 5’‐phosphate dramatically increased the potency of the inhibitors.
- 14 December 2021
- Published by Wiley in ChemMedChem
- Vol. 17 (5) , e202100603
Open Access5’‐Phosphorylation Increases the Efficacy of Nucleoside Inhibitors of the DNA Repair Enzyme SNM1A
Certain cancers exhibit upregulation of DNA interstrand crosslink repair pathways, which contributes to resistance to crosslinking chemotherapy drugs and poor prognoses. Inhibition of enzymes implicated in interstrand crosslink repair is therefore a promising strategy for improving the efficacy of cancer treatment. One such target enzyme is SNM1A, a zinc co‐ordinating 5’–3’ exonuclease. Previous studies have demonstrated the feasibility of inhibiting SNM1A using modified nucleosides appended with zinc‐binding groups. In this work, we sought to develop more effective SNM1A inhibitors by exploiting interactions with the phosphate‐binding pocket adjacent to the enzyme's active site, in addition to the catalytic zinc ions. A series of nucleoside derivatives bearing phosphate moieties at the 5’‐position, as well as zinc‐binding groups at the 3’‐position, were prepared and tested in gel‐electrophoresis and real‐time fluorescence assays. As well as investigating novel zinc‐binding groups, we found that incorporation of a 5’‐phosphate dramatically increased the potency of the inhibitors.